Initiates in Medical News
Navigation Links
Initiates in Medical News
Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis
THE WOODLANDS, Texas, Aug. 4 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has initiated a Phase 2 cli...Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe
SEATTLE, July 29 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that it was notified by the European Medicines Agency ("EMEA") that pixantrone is eligible to be submitted for a Marketing Authorization Application ("MAA") through...Merrimack Pharmaceuticals' second of five oncology pipeline candidates, MM-111, a bispecific antibody, has entered clinical development. Preclinical studies have demonstrated that the bispecific approach shows antitumor activity in a wide range of tumor types. The current Phase 1/2 study will eva...
Company Enrolls First Patient into SPIRIT PRIME Trial in the United States ABBOTT PARK, Ill., June 16 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT ) today announced the initiation of SPIRIT PRIME, a clinical trial to study the performance of the company's next-generation XIENCE PRIME(TM) E...
- PSI-7851 was generally safe and well tolerated in Phase 1a single ascending dose trial - Further results from single ascending and multiple ascending dose trials are expected in second half 2009 PRINCETON, N.J., June 9 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ) annou...
70 Years of Service Excellence and Innovation Leads Radiology Group to Select MEDxConnect(TM) System to Virtualize Workflow to Improve Patient Care and Increase Productivity CHARLOTTE, N.C., June 5 /PRNewswire/ -- Compressus, leaders in interoperability of disparate healthcare IT systems, ann...
Celator(R) Pharmaceuticals Initiates Research Agreement With Cephalon, Inc.
PRINCETON, N.J., May 21 /PRNewswire/ -- Celator Pharmaceuticals today announced that it has entered into a research agreement with Cephalon, Inc. (Nasdaq: CEPH ). The research agreement provides for the exploration of the application of Celator's proprietary technology to an ongoing drug develo...Dolce Hotels and Resorts Initiates Program to Mitigate H1N1 Flu Risk
MONTVALE, N.J. May 7 /PRNewswire/ -- Acting in response to concerns about H1N1 influenza , Dolce Hotels and Resorts (TM), a privately held operator of 24 upscale hotels, resorts and conference centers in North America and Europe, today announced a three-phase program to mitigate the risk to ...Telesso initiates post-market head-to-head peripheral IV catheter study
SYDNEY, Australia April 22, 2009 Telesso Technologies Limited, a global healthcare company, announced today that Miami Children's hospital is the first site to enroll patients in a head-to-head trial evaluating its FDA-approved guide wire-assisted peripheral IV catheter versus the industry's gol...Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
MOBILITY trial showcases company's leadership in developing innovative endovascular treatment options ABBOTT PARK, Ill., April 1 /PRNewswire-FirstCall/ -- Abbott ( NYSE: ABT ) today announced the initiation of MOBILITY, a clinical trial studying the safety and efficacy of the Absolute Pro(T...SAN FRANCISCO, March 24 /PRNewswire/ -- Epiphany Biosciences announced today that the company plans on filing an IND with the Food and Drug Administration (FDA) to study the potential impact of using the antiviral medication valomaciclovir (EPB-348) as an adjunctive therapy in the treatment of mul...
GSK Initiates Phase III Programme for Novel Type 2 Diabetes Medication, Syncria(R) (albiglutide)
LONDON, Feb. 17 /PRNewswire-FirstCall/ -- GlaxoSmithKline today announced initiation and dosing of the first patient of the Phase III clinical trial programme to evaluate the efficacy, safety and tolerability of the investigational GLP-1 (Glucagon-like peptide 1) agonist Syncria(R) (albiglutide) i...HAYWARD, Calif., Feb. 10 /PRNewswire/ -- Arete Therapeutics Inc. today announced the initiation of a Phase IIa clinical trial for AR9281, an orally- administered soluble epoxide hydrolase (s-EH) inhibitor being developed for the treatment of type 2 diabetes. S-EH is an enzyme involved in the m...
KING OF PRUSSIA, Pa., Dec. 11 /PRNewswire/ -- Emerging Growth Equities, Ltd. initiates coverage of PolyMedix Inc. (OTC Bulletin Board: PYMX) with a BUY rating and a $9.00 price target. PolyMedix focuses on developing novel high-value therapeutic drug products for serious, life-threatening acute d...
Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder
WALTHAM, Mass., Nov. 6 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) announced today that the Company has initiated a Phase 2b clinical trial to evaluate the use of RG2417, an oral formulation of uridine, in patients with bipolar depression. This Phase 2b study is a multi-cen...Cardiac Science Initiates Voluntary Field Corrective Action of Certain AEDs
No interruption to shipments or service to new or existing customers. BOTHELL, Wash., Oct. 13 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX ) announced today that it has initiated a worldwide voluntary field corrective action of certain automated external defibrillators...Ortho-McNeil initiates first-of-its-kind skin infection registry
Raritan, NJ, August 6, 2008 The nation's first, prospective registry of complicated skin and soft tissue infections (cSSTIs), known as SSTIR (the Skin and Soft Tissue Infection Hospital Registry), has begun enrolling patients. The SSTIR, plans to enroll more than 1,200 hospitalized patients by th...Ben-Gurion University of the Negev initiates project to eliminate intestinal worms in Ethiopia
NEW YORK, August 6, 2008 A professor at The Faculty of Health Sciences at Ben-Gurion University of the Negev (BGU) is beginning an intensive program in Ethiopia this August to eradicate intestinal worms which affect as much as 50 percent of the population in Africa. BGU Professor Zvi Bentwich,...COLUMBUS, Ohio, July 14 /PRNewswire/ -- Roxane Laboratories, Inc. announced today that it is conducting a nationwide voluntary recall of two manufacturing lots of Sodium Polystyrene Sulfonate Suspension, USP, 15 g/60 mL Unit dose bottles (NDC 0054-0165-51; Lot 856396A Exp April 2010, and Lot 8...
Rice Memorial Hospital and University of Tennessee Medical Center representatives available at the ASHP 2008 Summer Meeting and Exhibition, Omnicell booth #420 MOUNTAIN VIEW, Calif. and KNOXVILLE, Tenn., June 2 /PRNewswire-FirstCall/ -- Omnicell, Inc., (Nasdaq: OM...
Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE)
LOS ANGELES, May 20 /PRNewswire/ -- Vista Partners announced today that it has initiated coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE ). Ross Silver, Director of Research of Vista Partners stated, "Alseres' recombinant-protein-based drug named Cethrin has shown highly encouraging c...HUDSON, N.H., May 12 /PRNewswire/ -- Atrium Medical Corporation today announced that it is initiating a voluntary and precautionary recall of selected lots of HYDRAGLIDE(TM) Brand Heparin-Coated Thoracic Drainage Catheters. Limited lots of Atrium heparin-coated Hydraglide Thoracic Catheters we...
QLT initiates phase II study of punctal plug drug delivery system for glaucoma & ocular hypertension
VANCOUVER, March 31 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) announced today the initiation of patient recruitment into its "CORE" study, a phase II trial being conducted by QLT's wholly-owned subsidiary, QLT Plug Delivery, Inc. ("QPD"), to evaluate the preliminary efficacy a...Vista Partners Initiates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx)
LOS ANGELES, March 18 /PRNewswire/ -- Vista Partners announced today that it has initiated coverage on leading Australian biotechnology company Arana Therapeutics, (ASX: AAH; AIM: AAHx). "Cash on hand and royalty revenue alone are equal to roughly US$0.94 in share value. Add to that our US$0.4...MGH initiates phase I diabetes trial
BOSTON, MA Scientists at the Massachusetts General Hospital (MGH) have initiated a phase 1 clinical trial to reverse type 1 diabetes. The trial is exploring whether the promising results from the laboratory of Denise Faustman, MD, PhD, can be applied in human diabetes. Faustmans previous studies...Wasserman Morris Initiates Research Coverage on Crdentia
Rated Speculative Buy, $0.51 Price Target DALLAS, March 11 /PRNewswire-FirstCall/ -- Crdentia Corp. (OTC Bulletin Board: CRDT), a leading healthcare staffing company, today announced that Wasserman Morris & Company, an independent investment research firm, initiated coverage on ...Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
- Formulation Has Potential to Address Large Acute Pain Prescription Drug Market - LAVAL, QC, March 10 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it has begun enrolling patients in its Phase III clinical trial for its twi...Akela Pharma initiates its first abuse deterrent opioid Phase I clinical trial
http://www.akelapharma.com Toronto Stock Exchange Symbol: AKL MONTREAL, March 6 /PRNewswire-FirstCall/ - Akela Pharma Inc. (TSX: "AKL"), a drug development company focused on developing therapies for the inhalation and pain markets, today announced that it has started its first EDAC...AAP Initiates Public Relations Effort to Counter Bad Vaccine Publicity
National Autism Association Requests AAP Instead Focus on Removing Unnecessary Toxins From Vaccines and Providing Medical Treatments for Children with Autism CHICAGO, Feb. 15 /PRNewswire-USNewswire/ -- The American Academy of Pediatrics (AAP) has initiated a "parent spokesperson" campaign ...China Holdings Announces Starwood Research Institute Initiates Research Coverage
LAS VEGAS and BEIJING, Feb. 15 /Xinhua-PRNewswire-FirstCall/ -- China Holdings, Inc. (OTC Bulletin Board: CHHL), a global diversified assets holdings company, and its subsidiaries engage in multiple China-focused business activities including energy, renewable energy, resources, finance, real ...Edwards Lifesciences Initiates Patent Infringement Litigation Against CoreValve in the U.S.
IRVINE, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW ), the world leader in the science of heart valves, announced today that it has filed a patent infringement lawsuit against CoreValve, Inc., of Irvine, Calif., in the United States District Court for ...PreMD Initiates FDA Review Process and Provides Corporate Update
TORONTO, Feb. 12 /PRNewswire-FirstCall/ - Predictive medicine company PreMD Inc. (TSX: PMD; Amex: PME) today provided an update on the company's business direction in light of the recent decision from the U.S. Food and Drug Administration (FDA). Appeal to the FDA PreMD today filed a reques...Investor Insight Initiates Analyst Coverage on Crdentia
Analyst Rates Speculative Buy, $0.61 Price Target DALLAS, Feb. 11 /PRNewswire-FirstCall/ -- Crdentia Corp. (OTC Bulletin Board: CRDT), a leading healthcare staffing company, today announced that the independent research firm Investor Insight, an operating division of Doty-Scott Ente...QRxPharma Initiates Second Phase III Clinical Trial for its 'Dual Opioid' Pain Therapy
Safety extension study to be part of NDA submission in 2009 SYDNEY, Australia, Dec. 13 /PRNewswire/ -- QRxPharma (ASX: QRX) announced today the initiation of a second Phase III clinical trial for its lead product candidate Q8003IR, an immediate release dual-opioid pain therapy. This placeb...WELLINGTON, Fla., Dec. 13 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (Amex: QGP, QGP.U) ( http://www.QuantumMD.com ) today announced that it has completed its registered public offering, raising $13.2 million in gross proceeds. The Company further announced that it has initiated trading...
Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma
Summary: Genmab has Initiated a Phase II Study of Ofatumumab in Relapsed Diffuse Large B-Cell Lymphoma COPENHAGEN, Denmark, December 13 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today that study centers have been initiated and are ready to enroll patients in...Panacea Pharmaceuticals Initiates GMP Manufacturing of Prostate Cancer Diagnostic Test Kits
GAITHERSBURG, Md., Dec. 11 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. has initiated manufacturing of PC Detect(SM) kits, the Company's diagnostic test for prostate cancer, under GMP conditions. Data on the performance of the PC Detect(SM) kit will be included in a Premarket Approval (PMA) a...HEI, Inc. Initiates Delisting and Deregistration of Its Shares on NASDAQ
MINNEAPOLIS, Dec. 7 /PRNewswire-FirstCall/ -- HEI, Inc. (Nasdaq: HEII ) ( http://www.heii.com ) announced today that it has voluntarily initiated the process of delisting its common stock from NASDAQ Capital Market and withdrawing its common stock from registration. The Company provided notic...BioSeek Initiates Systems Biology Compound Evaluation Collaboration with UCB
BURLINGAME, Calif., Dec. 5 /PRNewswire/ -- BioSeek, Inc., a leader in applying integrated human biology systems for developing new therapeutics, announced today that it has entered into a collaboration agreement with UCB, a global biopharmaceutical leader based in Belgium. Under the collaborat...Conference Call & Webcast Today at 10:30 CET AMSTERDAM, November 27 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced it has signed an agreement with Digna Biotech/CIMA for the development of A...
Other TagsakaakaakaEBTCTSCTSCTSCTSCTSCTSNaturaleMatteMatteMatteSDUSDUSSDOther Contentsapoptosisapoptosisapoptosisapoptosisapoptosisapoptosisapoptosisarchaeaarchaeaarchaeaartificialartificialartificialartificialartificialartificialartificialartificialtechniquetechniquetechniquetechniquetechniquetechniquetechniquetechniquetechniqueasepticasepticasepticsynthasesynthasesynthasesynthasesynthase
(Date:11/24/2009)...to understanding how sounds associated with Navy s...or if they hear it at all. , The same type of la... to detect flaws in the space shuttle,s behemoth s...ek inside the giant head of a whale. The scans are...a whale,s hearing anatomy using a breakthrough met...
(Date:11/24/2009)...ble class of ring-shaped protein motors has been u... National Laboratory (Berkeley Lab) using a state-... Advanced Light Source (ALS). These protein motors...tion, and are vital to the survival of all biologi...he human papillomavirus, which has been linked to ...
(Date:11/24/2009)...eld secrets of the earth,s history locked in its i... little information on the environments that have ...ears. Now, a team of researchers from nine institu... of $10 million dollars by the National Science Fo...literally. These scientists will drill through the...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4LSU gets to the bottom of things -- in Antarctica 2Unprecedented Scale Up of Voluntary Male Circumcision Begins in Swaziland and Zambia 48558 1Unprecedented Scale Up of Voluntary Male Circumcision Begins in Swaziland and Zambia 48558 2Cord Blood America Continuing European Expansion 48557 1Cord Blood America Continuing European Expansion 48557 2A WIT Technologies Releases World 26apos 3Bs First Low Cost C Stamp 28TM 29 Based Biotechnology Laboratory in a Box 12572 1A WIT Technologies Releases World 26apos 3Bs First Low Cost C Stamp 28TM 29 Based Biotechnology Laboratory in a Box 12572 2(Date:11/27/2009)...wswire/ -- Considered a highly risky and controver...gan transplantation is now a life-saving mainstrea...men who gathered at the Winspear Opera House in Da...l centers around the world to celebrate the 25th a... (BRTI), one of the pioneers of solid organ transp...
(Date:11/27/2009).... 27 Team Garmin-Slipstream, the e...to ethical sporting and developing the next genera... will become Team Garmin-Transitions with the addi...e team. Transitions Optical is the world,s leading...st advanced photochromic technology in the widest ...
(Date:11/27/2009)...es may reduce future disease burden, researchers s...-- Encouraging city dwellers to walk and bicycle i...ic health benefits than increased used of low-emis...he study compared the projected health effects in ... for London, England, and Delhi, India: business-...
(Date:11/27/2009)...e; announced today that Spectrum Health (Grand Rap...se orthopedic templating solution and its TraumaCa... (PRWEB) November 27, 2009 -- Voyant Health&tr...apids, Michigan) has licensed its TraumaCad Enterp...Cad Extend workflow solution, to allow its orthope...
(Date:11/27/2009)...ive anatomy education apps from Modality and Lippi...s learning opportunities for iPhone and iPod touch...ember 27, 2009 -- Modality, Inc. and Lippincott ...s Kluwer Health, today announced the availability ...re. Clemente’s Anatomy, Rohen’s Photog...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5[0] Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary[0] Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor[0] More Foot Power, Less Car Pollution Best for Health[0] Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend[0] Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |